C
Cullinan Therapeutics, Inc.
CGEM · NASDAQ · Healthcare · 1.3B
Closing price
$15.53
+0.45% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
2.2×
Enterprise value / EBITDAEV/EBITDA
-3.8×
Free cash flow yieldFCF yield
-19.2%
Return on equityROE
-53.8%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.4×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.